JP2003530872A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003530872A5 JP2003530872A5 JP2001578467A JP2001578467A JP2003530872A5 JP 2003530872 A5 JP2003530872 A5 JP 2003530872A5 JP 2001578467 A JP2001578467 A JP 2001578467A JP 2001578467 A JP2001578467 A JP 2001578467A JP 2003530872 A5 JP2003530872 A5 JP 2003530872A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- polynucleotide
- symbol
- seq
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001184 polypeptide Polymers 0.000 description 28
- 102000004196 processed proteins & peptides Human genes 0.000 description 28
- 108090000765 processed proteins & peptides Proteins 0.000 description 28
- 239000002157 polynucleotide Substances 0.000 description 20
- 102000040430 polynucleotide Human genes 0.000 description 20
- 108091033319 polynucleotide Proteins 0.000 description 20
- 239000000203 mixture Substances 0.000 description 12
- 229960005486 vaccine Drugs 0.000 description 11
- 239000012634 fragment Substances 0.000 description 10
- 239000002773 nucleotide Substances 0.000 description 10
- 125000003729 nucleotide group Chemical group 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 238000000926 separation method Methods 0.000 description 9
- 125000003275 alpha amino acid group Chemical group 0.000 description 6
- 230000002163 immunogen Effects 0.000 description 6
- 241000194017 Streptococcus Species 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 241000186359 Mycobacterium Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 description 1
- 229940116224 behenate Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20007400P | 2000-04-27 | 2000-04-27 | |
| US60/200,074 | 2000-04-27 | ||
| PCT/US2001/013828 WO2001081380A2 (en) | 2000-04-27 | 2001-04-27 | Immunogenic pneumococcal protein and vaccine compositions thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003530872A JP2003530872A (ja) | 2003-10-21 |
| JP2003530872A5 true JP2003530872A5 (enExample) | 2008-07-03 |
Family
ID=22740214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001578467A Pending JP2003530872A (ja) | 2000-04-27 | 2001-04-27 | 免疫原肺炎連鎖球菌タンパク質とそのワクチン組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6689369B2 (enExample) |
| EP (1) | EP1278856A2 (enExample) |
| JP (1) | JP2003530872A (enExample) |
| AU (2) | AU2001255772B2 (enExample) |
| CA (1) | CA2407455A1 (enExample) |
| WO (1) | WO2001081380A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6800744B1 (en) * | 1997-07-02 | 2004-10-05 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| US6858706B2 (en) * | 1998-04-07 | 2005-02-22 | St. Jude Children's Research Hospital | Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| NZ530277A (en) * | 1998-04-07 | 2005-08-26 | Medimmune Inc | Derivatives of pneumococcal choline binding proteins for vaccines |
| KR100886095B1 (ko) | 2001-04-16 | 2009-02-27 | 와이어쓰 홀딩스 코포레이션 | 폴리펩티드 항원을 암호화하는 신규한 스트렙토코쿠스 뉴모니애 개방형 판독 프레임 및 이를 포함하는 조성물 |
| GB0714963D0 (en) | 2007-08-01 | 2007-09-12 | Novartis Ag | Compositions comprising antigens |
| SI2268618T1 (sl) | 2008-03-03 | 2015-09-30 | Novartis Ag | Spojine in sestavki kot modulatorji aktivnosti TLR |
| CA2765112A1 (en) | 2009-06-10 | 2010-12-16 | Novartis Ag | Benzonaphthyridine-containing vaccines |
| JO3257B1 (ar) | 2009-09-02 | 2018-09-16 | Novartis Ag | مركبات وتركيبات كمعدلات لفاعلية tlr |
| US9950062B2 (en) | 2009-09-02 | 2018-04-24 | Glaxosmithkline Biologicals Sa | Compounds and compositions as TLR activity modulators |
| CN102695523A (zh) | 2009-09-10 | 2012-09-26 | 诺华有限公司 | 针对呼吸道疾病的组合疫苗 |
| WO2011057148A1 (en) | 2009-11-05 | 2011-05-12 | Irm Llc | Compounds and compositions as tlr-7 activity modulators |
| JP5814933B2 (ja) | 2009-12-15 | 2015-11-17 | ノバルティス アーゲー | 免疫増強化合物の均質な懸濁物およびその使用 |
| EA031379B1 (ru) | 2010-03-23 | 2018-12-28 | Новартис Аг | Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний |
| WO2012072769A1 (en) | 2010-12-01 | 2012-06-07 | Novartis Ag | Pneumococcal rrgb epitopes and clade combinations |
| WO2013131983A1 (en) | 2012-03-07 | 2013-09-12 | Novartis Ag | Adjuvanted formulations of streptococcus pneumoniae antigens |
| US9827190B2 (en) | 2013-02-01 | 2017-11-28 | Glaxosmithkline Biologicals Sa | Intradermal delivery of immunological compositions comprising toll-like receptor 7 agonists |
| BR112020016314A2 (pt) | 2018-02-12 | 2020-12-15 | Inimmune Corporation | Compostos ou um sais farmaceuticamente aceitáveis, composição farmacêutica, kit, e, métodos para elicitar, intensificar ou modificar uma resposta imunológica, para tratar, prevenir ou reduzir a suscetibilidade a câncer, para tratar, prevenir ou reduzir a suscetibilidade a uma doença infecciosa, para tratar, prevenir ou reduzir a suscetibilidade a uma alergia, para tratar, prevenir ou reduzir a suscetibilidade a uma afecção autoimune, para tratar, prevenir ou reduzir a suscetibilidade em um sujeito à infecção bacteriana, viral, priônica, autoimunidade, câncer ou alergia, para tratar, prevenir ou reduzir a suscetibilidade à autoimunidade, alergia, reperfusão de isquemia ou sepse, para tratar, prevenir ou reduzir a gravidade de ataques epiléticos e para tratar, prevenir ou reduzir a suscetibilidade a doenças oculares como degeneração macular, hipertensão ocular e infecção ocular |
| KR20230117105A (ko) | 2020-11-04 | 2023-08-07 | 엘리고 바이오사이언스 | 큐티박테리움 아크네스 재조합 파지, 그의 제조 방법 및 용도 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0956289A4 (en) * | 1996-08-16 | 2004-10-13 | Smithkline Beecham Corp | NOVEL PROKARYOTA POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF |
| ATE348887T1 (de) * | 1996-10-31 | 2007-01-15 | Human Genome Sciences Inc | Streptococcus pneumoniae antigene und impfstoffe |
-
2001
- 2001-04-27 CA CA002407455A patent/CA2407455A1/en not_active Abandoned
- 2001-04-27 JP JP2001578467A patent/JP2003530872A/ja active Pending
- 2001-04-27 AU AU2001255772A patent/AU2001255772B2/en not_active Ceased
- 2001-04-27 EP EP01928972A patent/EP1278856A2/en not_active Ceased
- 2001-04-27 WO PCT/US2001/013828 patent/WO2001081380A2/en not_active Ceased
- 2001-04-27 US US09/844,124 patent/US6689369B2/en not_active Expired - Lifetime
- 2001-04-27 AU AU5577201A patent/AU5577201A/xx active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7641512B2 (ja) | Ｔｌｒ７アゴニストにカップリングする新規コロナウイルスポリペプチドワクチンおよびその適用 | |
| AU2007271350B2 (en) | Small Streptococcus pyogenes antigens and their use | |
| JP2002542827A5 (enExample) | ||
| CA2371714A1 (en) | Streptococcus pneumoniae proteins and vaccines | |
| CN103068838B (zh) | 基于重组蛋白的抗链球菌感染疫苗 | |
| RU2757426C2 (ru) | Иммунногенный слитый белок | |
| JP2002507396A5 (enExample) | ||
| RU2008150400A (ru) | Новая детерминанта вирулентности в пределах структурного гликопротеина е2 вируса классической лихорадки свиней | |
| JP2003501110A5 (enExample) | ||
| CN113801207B (zh) | 新型冠状病毒的串联表位多肽疫苗及其应用 | |
| JP2011506433A5 (enExample) | ||
| JP5437813B2 (ja) | Ｓ．アガラクティエの防御タンパク質、その組み合わせ、およびそれを使用する方法 | |
| JP2002512800A5 (enExample) | ||
| JP2001516583A5 (enExample) | ||
| KR102675881B1 (ko) | Pedv 스파이크 단백질 s1 유래 단백질 및 페리틴 유래 단백질을 포함하는 재조합 단백질 및 이의 용도 | |
| KR102675880B1 (ko) | SARS-CoV-2 스파이크 단백질 및 면역글로불린의 Fc 유래 단백질을 포함하는 재조합 단백질 및 이의 용도 | |
| JP2024512722A (ja) | 免疫原性融合タンパク質 | |
| CN107974458A (zh) | 表达猪丹毒杆菌重组蛋白GAPDH的基因gapdh及其重组大肠杆菌与应用 | |
| CN118873646A (zh) | 一种抑制a组链球菌感染的重组蛋白疫苗及其应用 | |
| KR102675879B1 (ko) | SARS-CoV-2 스파이크 단백질 S1 유래 단백질 및 페리틴 유래 단백질을 포함하는 재조합 단백질 및 이의 용도 | |
| CN114437235A (zh) | 马链球菌马亚种8种蛋白的重组融合蛋白及其制备方法和应用 | |
| US7041295B2 (en) | Compounds for treatment of infectious and immune system disorders and methods for their use | |
| JP2004502782A5 (enExample) | ||
| WO2023044327A1 (en) | Recombinant vaccine compositions | |
| Yu et al. | A DNA vaccine encoding the FMDV capsid precursor polypeptide P1 and the enhancing effect of bovine herpesvirus 1 VP22 protein as molecular adjuvant |